These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24258097)

  • 1. How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?
    Halim LA; Brinks V; Jiskoot W; Romeijn S; Praditpornsilpa K; Assawamakin A; Schellekens H
    Pharm Res; 2014 May; 31(5):1210-8. PubMed ID: 24258097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin.
    Skibeli V; Nissen-Lie G; Torjesen P
    Blood; 2001 Dec; 98(13):3626-34. PubMed ID: 11739166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of illegal trade on the quality of epoetin alfa in Thailand.
    Fotiou F; Aravind S; Wang PP; Nerapusee O
    Clin Ther; 2009 Feb; 31(2):336-46. PubMed ID: 19302906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPLC-MS assessment on the structural similarity of recombinant human erythropoietin (rhEPO) analogues from manufacturers in China for attribute monitoring.
    Alley W; Tao L; Shion H; Yu YQ; Rao C; Chen W
    Talanta; 2020 Dec; 220():121335. PubMed ID: 32928385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of 96-well microplates coated with molecularly imprinted polymer for determination and biosimilarity assessment of recombinant human erythropoietin.
    El-Aal MAA; Al-Ghobashy MA; El-Saharty YS
    J Chromatogr A; 2021 Mar; 1641():462012. PubMed ID: 33647538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of recombinant human erythropoietin in drug formulations by high-performance capillary electrophoresis.
    Bietlot HP; Girard M
    J Chromatogr A; 1997 Jan; 759(1-2):177-84. PubMed ID: 9050223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acid-specific affinity chromatography for the separation of erythropoietin glycoforms using serotonin as a ligand.
    Meininger M; Stepath M; Hennig R; Cajic S; Rapp E; Rotering H; Wolff MW; Reichl U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():193-203. PubMed ID: 26851523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically active recombinant human erythropoietin expressed in hairy root cultures and regenerated plantlets of Nicotiana tabacum L.
    Gurusamy PD; Schäfer H; Ramamoorthy S; Wink M
    PLoS One; 2017; 12(8):e0182367. PubMed ID: 28800637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of anti-recombinant human erythropoietin (rhEPO) monoclonal antibody.
    Yan J; Wang S; Mi JB; Guo ZQ; Chang WB
    J Immunoassay Immunochem; 2004; 25(1):91-101. PubMed ID: 15038620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-clinical safety studies on biosimilar recombinant human erythropoietin.
    Parnham MJ; Schindler-Horvat J; Kozlović M
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):73-83. PubMed ID: 17244255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection in blood and urine of recombinant erythropoietin administered to healthy men.
    Wide L; Bengtsson C; Berglund B; Ekblom B
    Med Sci Sports Exerc; 1995 Nov; 27(11):1569-76. PubMed ID: 8587495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and preliminary application of monoclonal antibody against recombinant human erythropoietin].
    Wang YF; Peng J; Cai YF; Ni YM; Zhao JY; Cheng GX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):696-8. PubMed ID: 15555438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro bioassay for human erythropoietin based on proliferative stimulation of an erythroid cell line and analysis of carbohydrate-dependent microheterogeneity.
    Hammerling U; Kroon R; Wilhelmsen T; Sjödin L
    J Pharm Biomed Anal; 1996 Aug; 14(11):1455-69. PubMed ID: 8877851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic separation of recombinant human erythropoietin isoforms.
    Gokana A; Winchenne JJ; Ben-Ghanem A; Ahaded A; Cartron JP; Lambin P
    J Chromatogr A; 1997 Dec; 791(1-2):109-18. PubMed ID: 9463897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO.
    Bader A; Ebert S; Giri S; Kremer M; Liu S; Nerlich A; Günter CI; Smith DU; Machens HG
    Int J Nanomedicine; 2012; 7():1227-37. PubMed ID: 22419870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Recombinant Human Erythropoietin on MPC-11 Myeloma Cells Cultured In Vitro].
    Zeng Y; Zhou JL; Xu CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1460-1465. PubMed ID: 29070125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality and Batch-to-Batch Consistency of Original and Biosimilar Epoetin Products.
    Halim LA; Brinks V; Jiskoot W; Romeijn S; Haselberg R; Burns C; Wadhwa M; Schellekens H
    J Pharm Sci; 2016 Feb; 105(2):542-550. PubMed ID: 26869417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
    Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A
    Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved method for the purification of human erythropoietin with high in vivo activity from the urine of anemic patients.
    Inoue N; Wada M; Takeuchi M
    Biol Pharm Bull; 1994 Feb; 17(2):180-4. PubMed ID: 8205112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.